Canadian access and provincial variation posts 61–81
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
My position on canadian access and provincial variation is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
The public assessment documents published at approval are free, detailed and largely unread here.
I would want a second opinion before relying on that.
Post #60 and I disagree about the size of the effect, not about the direction.
Where the canadian access and provincial variation discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
I read the earlier replies on canadian access and provincial variation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
Sensible. I would want the same detail before I acted on it either.
Worth separating two things that post #64 runs together.
A note on how canadian access and provincial variation gets discussed rather than on canadian access and provincial variation itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.
The arithmetic in post #66 is right; the assumption feeding it is the part to check.
Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Caveat: everything above assumes the paperwork is what it says it is.
Answering the question post #68 raises rather than the one it answers.
On canadian access and provincial variation I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get heated.
The most useful contribution is the current published criterion with a link and an access date, rather than an account of what happened to somebody.
Post #71 put the caveat in the right place and I want to underline it.
The question underneath canadian access and provincial variation is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.
Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.
Building on post #71 rather than restating it.
Small correction to my own earlier position on canadian access and provincial variation. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.
Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable.
I have no interest in any supplier named above.
Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream healthcare.
The confident answers on canadian access and provincial variation and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Taking post #75 at face value and following it one step further.
Adding the boring version of canadian access and provincial variation, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
Picking up post #78: that is the part I would want checked first.
Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write.
Happy to be the one who is wrong here if it settles the question.
This topic was referenced in
- Coverage in the US: a map of the usual obstaclesRegional › North America · 50 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
|
+46 | 50 | 7.9k | 5mo |
|
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
|
4 | 62k | 9mo | |
|
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A follow-up question about State-level differences that I did not know to ask the first time.…
|
+90 | 96 | 4.1k | 4mo |
|
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Telehealth prescribing models — I have the observation and I do not trust my…
|
+26 | 30 | 17k | 17h |
|
US compounding rules and how they changed
US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…
|
+62 | 68 | 1.4k | 20mo |
Related topics — sharing the tags compounding, telehealth, FDA
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. Official shortage notices — I have the observation and I do not trust my interpretation…
|
+39 | 43 | 510 | 17mo |
|
US compounding rules and how they changed
US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…
|
+62 | 68 | 1.4k | 20mo |
|
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Dated regional question, February 2026, because everything in…
|
+107 | 111 | 12k | 1d |
|
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…
|
+104 | 114 | 6.1k | 3h |
|
State-level differences that actually matter
On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…
|
+6 | 10 | 56k | 10mo |